Session Information
2011 Midyear Clinical Meeting
Click here to go to the previous page
Contemporary Considerations in Anticoagulation Management
Track:
Education Sessions (CE)
Program Code: 272-L01
Date: Thursday, December 8, 2011
Time: 2:00 PM to 4:00 PM EST
Location:
Room 354, Level 3
PRESENTER(S):
Mr. Jeremy DeGrado, Clinical Pharmacy Specialist, Critical Care
John Fanikos
Toby Trujillo
PROGRAM CHAIR:
Mr. Jeremy DeGrado, Clinical Pharmacy Specialist, Critical Care
- Describe new anticoagulants being developed, such as rivaroxaban and apixan; including their potential indications, roles, advantages, and disadvantages in various patient populations.
- Discuss key concepts and recent literature of new anticoagulant agents, such as dabigatran, and potential barriers to their use in specific patient populations.
- Evaluate recent literature on the pharmacogenomics of warfarin and the real world application for managing patients.
This session is a part of:
This session is a part of: